输血前四项感染指标联合测定的结果分析  

Analysis on combined determination of four infection indicators before blood transfusion

作　　者：王海滨[1] 石新慧[1] 

机构地区：[1]解放军总医院第一附属医院检验科,北京100048

出　　处：《中华实验和临床感染病杂志（电子版）》2013年第2期93-95,共3页Chinese Journal of Experimental and Clinical Infectious Diseases(Electronic Edition)

摘　　要：目的对受血者进行输血前血清学四项感染指标联合检测,了解受血者输血前感染指标的临床感染状况,并探讨其在避免输血性传播疾病导致的医疗纠纷中的重要意义。方法对本院2100例受血者在输血前进行乙型肝炎病毒表面抗原(HBsAg)、丙型肝炎病毒抗体(抗-HCV)、人类免疫缺陷病毒抗体(抗-HIV)和梅毒(TP)检测结果进行分析。结果入组患者中HBsAg、抗-HCV、抗-HIV和TP阳性率分别为9.10%、1.32%、0.15%和1.87%;HBsAg和抗-HCV均阳性者为10例,感染率为0.48%;抗-HCV和TP均阳性者为6例,感染率为0.28%。结论为既对患者负责,同时保护医务工作者自身利益,预防和避免不必要的由输血引起的医疗纠纷,受血者输血前必须行四项感染指标的联合检测。Objective To detect the four indicators of serological infection of blood recipients before blood transfusion, and to investigate the infection situation of the blood recipients and its significance of avoiding transfusion transmitted disease caused by medical malpractice. Methods HBsAg, anti-HCV, anti-HIV and TP of 2100 blood recipients in our hospital before blood transfusion were detected. Results Among the 2100 blood recipients, HBsAg positive rate was 9.10%, anti-HCV positive rate was 1.32%, anti- HIV positive rate was 0.15%, TP positive rate was 1.87%, HBsAg and anti-HCV were both positive in 10 cases, with the infection rate as 0.48%, anti-HCV and TP positive were both in 6 cases, with the infection rate as 0.28%. Conclusions Blood recipients should take the detection of four infection indicators before transfusion, in order to be responsible for the patients and protect medical workers＇ self-interest, and to prevent and avoid unnecessary medical malpractice due to blood transfusion.

关 键 词：输血 乙型肝炎病毒表面抗原 丙型肝炎病毒抗体 梅毒螺旋体抗体 人类免疫缺陷病毒抗体 

分 类 号：R446.6[医药卫生—诊断学]